REGENERON PHARMACEUTICALS, INC.

10-K & 10-Q Filings

Regeneron Pharmaceuticals, Inc. is a biotechnology company that invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its business strategy is to maintain a strong foundation in basic scientific research and discovery-enabling technologies and build on that foundation with clinical development, manufacturing, and commercial capabilities. The company's products include EYLEA® HD (aflibercept) for eye diseases, Dupixent® (dupilumab) for atopic dermatitis and asthma, Libtayo® (cemiplimab) for cancer, Praluent® (alirocumab) for high cholesterol, and Kevzara® (sarilumab) for rheumatoid arthritis, among others. Regeneron's products are sold in collaboration with Bayer, Sanofi, Roche, and Ultragenyx. The company's website is <https://www.regeneron.com>, and its ticker symbol is REGN.

12 mos ending Dec 31, 201112 mos ending Dec 31, 201212 mos ending Dec 31, 201312 mos ending Dec 31, 201412 mos ending Dec 31, 201512 mos ending Dec 31, 201612 mos ending Dec 31, 201712 mos ending Dec 31, 201812 mos ending Dec 31, 201912 mos ending Dec 31, 202012 mos ending Dec 31, 202112 mos ending Dec 31, 202212 mos ending Dec 31, 20233 mos ending Mar 31, 20233 mos ending Mar 31, 2024CAGR %YoY %Revenue (+)
$445.82
1378.48
2104.74
2819.56
4103.73
4860.43
5872.23
6710.80
7863.40
8497.10
16071.70
12172.90
13117.20
3162.10
3145.00
32.55%-0.54%Cost of Revenue (-)
$4.22
84.45
118.05
129.03
241.70
194.62
202.51
434.10
782.20
1119.90
2437.50
1560.40
1815.80
457.50
433.80
65.77%-5.18%Gross Profit (+)
$441.61
1294.02
1986.70
2690.53
3862.03
4665.80
5669.72
6276.70
7081.20
7377.20
13634.20
10612.50
11301.40
2704.60
2711.20
31.02%0.24%Selling, General & Administrative (-)
$117.26
210.75
329.42
504.75
838.53
1177.70
1320.43
1556.20
1834.80
1346.00
1824.90
2115.90
2631.30
601.10
689.00
29.59%14.62%Research & Development (-)
$529.51
625.55
859.95
1271.35
1620.58
2052.30
2075.14
2186.10
3036.60
2735.00
2908.10
3592.50
4439.00
1101.20
1248.40
19.39%13.37%Operating Expenses (-)
$646.77
836.31
1226.67
1852.10
2610.11
3335.06
3590.13
3742.30
4871.40
3800.60
4687.40
5873.60
7254.30
1757.90
1952.70
22.32%11.08%Costs & Expenses (Total) (-)
$650.98
920.76
1344.72
1981.13
2851.81
3529.69
3792.64
4176.40
5653.60
4920.50
7124.90
7434.00
9070.10
2215.40
2393.60
24.55%8.04%Operating Income/Loss (+)
$-205.16
457.71
760.03
838.43
1251.92
1330.74
2079.59
2534.40
2209.80
3576.60
8946.80
4738.90
4047.10
946.70
751.40
-20.63%Non-operating Income/Expense (+)
$-17.73
-43.29
-46.67
-62.68
-26.82
-0.93
-1.08
19.10
219.30
233.80
379.00
119.90
152.20
-88.70
-50.70
42.84%Interest Expense (-)
$-21.28
45.30
46.44
37.37
14.24
7.20
25.12
28.20
30.20
56.90
57.30
59.40
73.00
18.00
16.10
-10.56%Earnings before Tax (+)
$-222.89
414.42
713.36
775.75
1225.10
1329.82
2078.51
2553.50
2429.10
3810.40
9325.80
4858.80
4199.30
858.00
700.70
-18.33%Tax Expense (-)
$-1.13
-335.85
289.00
427.67
589.04
434.29
880.00
109.10
313.30
297.20
1250.50
520.40
245.70
40.20
-21.30
-152.99%Income/Loss (Continuing Operations) (+)
$-221.76
750.27
424.36
348.07
636.06
895.52
1198.51
2444.40
2115.80
3513.20
8075.30
4338.40
3953.60
817.80
722.00
-11.71%Net Income/Loss (+)
$-221.76
750.27
424.36
348.07
636.06
895.52
1198.51
2444.40
2115.80
3513.20
8075.30
4338.40
3953.60
817.80
722.00
-11.71%Net Income/Loss (Common) (+)
$-221.76
750.27
424.36
348.07
636.06
895.52
1198.51
2444.40
2115.80
3513.20
8075.30
4338.40
3953.60
817.80
722.00
-11.71%EPS (Basic)
$-2.45
7.92
4.33
3.46
6.17
8.55
11.27
22.65
19.38
32.65
76.40
40.51
37.05
7.64
6.70
-12.30%EPS (Diluted)
$-2.45
6.75
3.81
3.07
5.52
7.70
10.34
21.29
18.46
30.52
71.97
38.22
34.77
7.17
6.27
-12.55%Weighted Avg Shares (Basic)
2.11
94.69
97.92
100.61
103.06
104.72
106.34
107.90
109.20
107.60
105.70
107.10
106.70
107.10
107.80
38.68%0.65%Weighted Avg Shares (Diluted)
115.38
111.29
113.41
115.23
116.37
115.95
114.80
114.60
115.10
112.20
113.50
113.70
114.00
115.10
0.96%Cash
$483.61
230.28
535.61
648.72
809.10
535.20
812.73
1467.70
1617.80
2193.70
2885.60
3105.90
2730.00
3916.30
2602.00
15.52%-33.56%Short-term Investments
$43.33
77.82
158.38
251.76
236.12
503.48
596.85
1342.20
1596.50
1393.30
2809.10
4636.40
8114.80
5043.40
7917.50
54.66%56.99%Receivables
$103.04
693.12
891.78
739.38
1152.49
1343.37
1538.64
1723.70
2100.00
3111.50
6036.50
5328.70
5667.30
5118.60
5222.20
39.65%2.02%Inventory
$
70.35
128.86
238.58
399.36
726.14
1151.20
1415.50
1916.60
1951.30
2401.90
2580.50
2424.70
2714.90
11.97%Prepaid Expenses (Current)
$22.90
56.66
96.14
71.49
163.50
130.53
224.97
243.30
387.10
160.80
332.40
411.20
386.60
406.20
414.90
26.56%2.14%Other Assets (Current)
$
148.13
44.68
327.25
315.30
268.25
435.70
519.50
572.20
1003.20
Assets (Current)
$652.88
1206.01
1796.93
2167.46
2915.09
3180.19
4335.03
6447.60
7689.10
9779.10
14014.90
15884.10
19479.20
16909.20
18871.50
32.71%11.60%Securities & Long-term Investments
$283.61
279.42
389.89
460.15
632.16
864.26
1486.49
1755.00
3256.80
3135.60
6838.00
6591.80
5396.50
6066.60
6978.80
27.83%15.04%Property, Plant & Equipment (Net)
$367.95
379.94
526.98
974.31
1594.12
2083.42
2358.61
2575.80
3221.60
3482.20
3763.00
4146.40
3880.90
4225.50
22.36%8.88%Goodwill & Intangibles
$
915.50
1038.60
928.70
1058.70
14.00%Other Assets
$19.14
215.12
237.20
269.90
467.75
845.60
584.16
956.10
3859.30
1027.00
1099.70
2060.10
3019.50
2274.50
3235.10
52.46%42.23%Assets (Non-current)
$670.71
874.48
1154.08
1704.37
2694.04
3793.28
4429.26
5286.90
7116.10
7384.20
11419.90
13330.40
13601.00
13150.70
15498.10
28.50%17.85%Assets (Total)
$1323.58
2080.49
2951.01
3871.83
5609.13
6973.47
8764.29
11734.50
14805.20
17163.30
25434.80
29214.50
33080.20
30059.90
34369.60
30.76%14.34%Accounts Payable
$95.63
111.34
250.90
484.23
644.11
879.10
815.08
218.20
418.10
475.50
564.00
589.20
606.60
599.50
671.30
16.64%11.98%Debt (Current)
$
127.27
719.70
Other Liabilities (Current)
$52.65
52.20
47.94
170.43
167.05
235.13
320.40
1224.60
1678.50
2221.90
2648.80
2552.10
2816.80
2500.60
2909.60
39.33%16.36%Liabilities (Current)
$148.27
163.55
298.83
654.66
811.16
1241.49
1135.48
1442.80
2096.60
2697.40
3932.50
3141.30
3423.40
3100.10
3580.90
29.90%15.51%Debt (Non-current)
$275.02
296.52
320.31
146.77
713.90
2695.70
1980.00
2701.40
2702.90
2701.80
2703.30
20.98%0.06%Other Liabilities
$414.56
375.04
379.79
528.07
1143.13
1282.73
1484.72
1534.40
905.00
744.90
753.50
707.80
980.80
762.80
1094.30
7.44%43.46%Liabilities (Non-current)
$689.58
671.55
700.10
674.84
1143.13
1282.73
1484.72
1534.40
1618.90
3440.60
2733.50
3409.20
3683.70
3464.60
3797.60
14.99%9.61%Liabilities (Total)
$837.85
835.11
998.94
1329.50
1954.30
2524.22
2620.21
2977.20
3715.50
6138.00
6666.00
6550.50
7107.10
6564.70
7378.50
19.50%12.40%Treasury Stock
$
-169.53
306.07
316.24
316.24
396.40
739.90
6613.30
8260.90
10353.30
12560.40
11045.50
12856.70
16.40%Retained Earnings
$-1267.32
-517.05
-92.69
255.38
852.70
1748.22
2946.73
5254.30
7379.80
10893.00
18968.30
23306.70
27260.30
24124.50
27982.30
15.99%AOCI
$-1.86
-1.17
-1.19
52.25
8.57
-12.84
0.64
-12.30
21.10
29.30
-26.20
-238.80
-80.90
-181.60
-77.20
57.49%Shareholder's Equity
$485.73
1245.38
1952.08
2542.33
3654.84
4449.24
6144.08
8757.30
11089.70
11025.30
18768.80
22664.00
25973.10
23495.20
26991.10
39.32%14.88%Liabilities & Equity
$1323.58
2080.49
2951.01
3871.83
5609.13
6973.47
8764.29
11734.50
14805.20
17163.30
25434.80
29214.50
33080.20
30059.90
34369.60
30.76%14.34%Net Income/Loss
$-221.76
750.27
424.36
348.07
636.06
895.52
1198.51
2444.40
2115.80
3513.20
8075.30
4338.40
3953.60
817.80
722.00
-11.71%Depreciation & Amortization
$
36.94
41.20
52.69
74.91
104.75
145.47
148.20
210.30
235.90
286.20
341.40
421.00
99.50
114.10
14.67%Increase/Decrease in Working Capital
$-36.84
672.80
190.67
46.37
-108.20
131.89
607.72
837.00
331.10
1428.00
2063.60
989.70
931.90
-24.40
-250.10
-925.00%Share-based Compensation
$56.09
94.16
198.40
307.24
459.05
559.88
507.28
427.40
464.30
432.00
601.70
725.00
885.00
238.70
230.10
25.84%-3.60%Adjustments to Reconcile Net Income
$80.08
-824.88
159.29
395.08
694.72
577.87
108.60
-249.30
314.20
-895.10
-994.00
676.50
640.40
549.80
790.50
18.92%43.78%Net Cash (Operating)
$-141.68
-74.61
583.65
743.16
1330.78
1473.40
1307.11
2195.10
2430.00
2618.10
7081.30
5014.90
4594.00
1367.60
1512.50
10.60%Capital Expenditure
$-57.22
49.34
156.32
333.01
677.93
511.94
272.63
383.10
429.60
614.60
551.90
590.10
773.50
178.20
133.90
-24.86%Net Cash (Investing)
$128.47
-81.07
-355.45
-420.78
-907.60
-1046.90
-1005.18
-1463.00
-2027.80
-70.60
-5384.70
-3784.60
-3185.10
-235.70
-1687.10
-615.78%Increase/Decrease in Debt
$0.99
-2.20
-2.02
-221.73
-140.45
-40.59
37.08
1981.90
Increase/Decrease in Equity
$112.31
63.55
57.39
-168.51
-367.13
-516.63
240.21
110.10
-64.10
-3271.60
26.90
-563.30
-1089.50
-225.50
390.80
273.30%Interest Expenses
$14.72
21.95
23.84
20.61
10.58
5.45
18.68
22.30
25.00
23.20
55.80
53.70
73.10
14.28%Net Cash (Financing)
$384.25
-97.65
77.14
-209.27
-262.80
-700.39
-24.40
-77.10
-252.10
-1970.50
-1005.80
-1009.00
-1790.10
-322.50
47.10
114.60%Cash Taxes Paid
$
59.85
276.09
481.36
754.84
205.60
342.30
188.10
1218.40
1502.40
870.30
Effect of Exchange Rate
$
-0.40
-0.50
Increase/Decrease in Cash
$371.04
-253.33
305.33
113.11
160.38
-273.90
277.53
655.00
150.10
577.00
690.80
221.30
-381.60
809.40
-128.00
-115.81%Cash (Beginning)
$112.57
483.61
230.28
535.61
648.72
809.10
535.20
825.20
1480.20
1630.30
2207.30
2898.10
3119.40
3119.40
2737.80
31.89%-12.23%Cash (Ending)
$483.61
230.28
535.61
648.72
809.10
535.20
812.73
1480.20
1630.30
2207.30
2898.10
3119.40
2737.80
3928.80
2609.80
15.54%-33.57%NOPAT
$-206.20
828.64
452.12
773.75
969.78
849.05
1324.36
2330.34
1898.40
3400.04
7777.92
3273.57
3208.34
902.34
774.24
-14.20%Gross Margin %
99.05%
93.87%
94.39%
95.42%
94.11%
96.00%
96.55%
93.53%
90.05%
86.82%
84.83%
87.18%
86.16%
85.53%
86.21%
Operating Margin %
-46.02%
33.20%
36.11%
29.74%
30.51%
27.38%
35.41%
37.77%
28.10%
42.09%
55.67%
38.93%
30.85%
29.94%
23.89%
NOPAT Margin %
-46.25%
60.11%
21.48%
27.44%
23.63%
17.47%
22.55%
34.73%
24.14%
40.01%
48.40%
26.89%
24.46%
28.54%
24.62%
Net Margin %
-49.74%
54.43%
20.16%
12.34%
15.50%
18.42%
20.41%
36.42%
26.91%
41.35%
50.25%
35.64%
30.14%
25.86%
22.96%
Tax Rate %
-0.51%
-81.04%
40.51%
7.71%
22.54%
36.20%
36.32%
8.05%
14.09%
4.94%
13.06%
30.92%
20.72%
4.69%
-3.04%
ROA
-15.58%
39.83%
15.32%
19.98%
17.29%
12.18%
15.11%
19.86%
12.82%
19.81%
30.58%
11.21%
9.70%
3.00%
2.25%
ROE
-42.45%
66.54%
23.16%
30.43%
26.53%
19.08%
21.55%
26.61%
17.12%
30.84%
41.44%
14.44%
12.35%
3.84%
2.87%
ROIC
-49.51%
73.32%
29.73%
47.57%
34.25%
24.64%
29.69%
42.11%
55.32%
44.31%
67.51%
26.89%
24.46%
8.04%
6.55%
Asset Turnover
0.34
0.66
0.71
0.73
0.73
0.70
0.67
0.57
0.53
0.50
0.63
0.42
0.40
0.11
0.09
Inventory Turnover
1.68
1.00
1.01
0.49
0.28
0.38
0.55
0.58
1.25
0.65
0.70
0.19
0.16
Equity Multiplier
2.72
1.67
1.51
1.52
1.53
1.57
1.43
1.34
1.34
1.56
1.36
1.29
1.27
1.28
1.27
Current Ratio
4.40
7.37
6.01
3.31
3.59
2.56
3.82
4.47
3.67
3.63
3.56
5.06
5.69
5.45
5.27
Quick Ratio
4.25
6.12
5.31
2.50
2.71
1.92
2.60
3.14
2.53
2.48
2.98
4.16
4.82
4.54
4.40
Debt/Equity Ratio
0.57
0.24
0.16
0.06
0.03
0.06
0.24
0.14
0.12
0.10
0.11
0.10
Interest Coverage Ratio
-13.93
20.86
31.88
40.67
118.31
243.99
111.34
113.65
88.39
154.16
160.34
88.25
55.36
Working Capital/Sales
0.11
0.54
0.47
0.23
0.30
0.28
0.36
0.44
0.44
0.52
0.50
0.62
0.60
2.03
2.08
R&D/Sales
1.19
0.45
0.41
0.45
0.39
0.42
0.35
0.33
0.39
0.32
0.18
0.30
0.34
0.35
0.40
Total Payout
$-98.58
-39.40
-31.53
410.85
518.16
562.67
-258.61
-87.80
89.10
1312.90
28.90
617.00
1162.60
225.50
-390.80
-273.30%Payout Ratio %
-47.81%
-4.75%
-6.97%
53.10%
53.43%
66.27%
-19.53%
-3.77%
4.69%
38.61%
0.37%
18.85%
36.24%
24.99%
-50.48%